Additionally, disruption of CXCR2-mediated MDSC tumor trafficking enhances anti-PD1 efficacy in rhabdomyosarcoma, the most common childhood soft tissue sarcoma [29]. Here, CXCR2 is linked to soft tissue sarcoma.